Impact of CPAP Level on V/Q Mismatch in Premature Infants
Impact of Continuous Positive Airway Pressure Level on Ventilation/Perfusion Mismatch in Premature Infants: a Phase II Clinical Trial
2 other identifiers
interventional
21
1 country
3
Brief Summary
Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for gas exchange. This study measure the responsiveness of V/Q mismatch to changes in the amount (or level) of CPAP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2017
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2016
CompletedFirst Posted
Study publicly available on registry
December 6, 2016
CompletedStudy Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2020
CompletedResults Posted
Study results publicly available
July 30, 2020
CompletedMarch 25, 2021
March 1, 2021
2.4 years
November 21, 2016
July 9, 2020
March 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilation/Perfusion Mismatch
Measured by non-invasive computerized technique based on curvilinear characteristics generated by a best-fit curve connecting the fractional inspired oxygen and corresponding peripheral oxygen saturation pairs; measured as difference in degree of right-shift between baseline and "best" CPAP
variable; up to 2 hours
Secondary Outcomes (1)
Best CPAP Level
variable, up to 2 hours
Study Arms (1)
Continuous positive airway pressure (CPAP) level changes
EXPERIMENTALProtocol guided changes in CPAP level from clinical baseline, with responsiveness in V/Q mismatch guiding subsequent changes; limited to a range of -2 to +3 cm H2O from baseline
Interventions
as per arm description
Eligibility Criteria
You may qualify if:
- Born at 27-35 weeks gestational age (GA) by best obstetric estimate, determined by the clinical obstetric team during antepartum admission.
- Age limits: 24 hours of age - 35 weeks corrected gestational age.
- On continuous CPAP support between 4-8 cm H2O for greater than 24 hours, as document on the bedside infant flow sheet.
- Supplemental oxygen requirement, with a fraction of inspired oxygen (FiO2) 0.25 for at least 2 consecutive hours, as documented on the bedside infant flow sheet.
You may not qualify if:
- Congenital anomalies, as determined by the clinical supervising physician.
- Current or prior air leak syndrome, as determined by the clinical supervising physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Philadelphialead
- Thrasher Research Fundcollaborator
Study Sites (3)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Pennsylvania Hosptital
Philadelphia, Pennsylvania, 19107, United States
Related Publications (1)
Bamat NA, Orians CM, Abbasi S, Morley CJ, Ross Russell R, Panitch HB, Handley SC, Foglia EE, Posencheg MA, Kirpalani H. Use of ventilation/perfusion mismatch to guide individualised CPAP level selection in preterm infants: a feasibility trial. Arch Dis Child Fetal Neonatal Ed. 2023 Mar;108(2):188-193. doi: 10.1136/archdischild-2022-324474. Epub 2022 Sep 14.
PMID: 36104165DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nicolas Bamat, MD MSCE
- Organization
- University of Pennsylvania
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas Bamat, MD, MSCE
University of Pennsylvania
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2016
First Posted
December 6, 2016
Study Start
February 1, 2017
Primary Completion
July 8, 2019
Study Completion
February 13, 2020
Last Updated
March 25, 2021
Results First Posted
July 30, 2020
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share